Reid ME, Calhoun L, Petz LD. Erythrocyte antigens and antibodies. In: Lichtman MA, Beutler E, Kipps TJ, et al., Eds. Williams hematology. 7th ed. New York: McGraw-Hill Medical, 2006:2119–36.ReidMECalhounLPetzLD.Erythrocyte antigens and antibodies. In: LichtmanMABeutlerEKippsTJ, Eds. Williams hematology. 7th ed. New York: McGraw-Hill Medical, 2006:2119–36.Search in Google Scholar
Reid ME, Westhoff CM. Membrane blood group antigens and antibodies. In: Hillyer CD, Silberstein LE, Ness PM, Anderson KC, Roback JD, Eds. Blood banking and transfusion medicine: basic principles and practice. 2nd ed. Philadelphia, PA: Churchhill Livingstone Elsevier, 2007:53–68.ReidMEWesthoffCM.Membrane blood group antigens and antibodies. In: HillyerCDSilbersteinLENessPMAndersonKCRobackJD Eds. Blood banking and transfusion medicine: basic principles and practice. 2nd ed. Philadelphia, PA: Churchhill Livingstone Elsevier, 2007:53–68.10.1016/B978-0-443-06981-9.50010-7Search in Google Scholar
Contreras M, Daniels G. Red cell immunohaematology: an introduction. In: Hoffbrand AV, Catovsky D, Tuddenham E, Eds. Postgraduate haematology. 6th ed. West Sussex, UK: Wiley-Blackwell, 2011:226–43.ContrerasMDanielsG.Red cell immunohaematology: an introduction. In: HoffbrandAVCatovskyDTuddenhamE Eds. Postgraduate haematology. 6th ed. West Sussex, UK: Wiley-Blackwell, 2011:226–43.Search in Google Scholar
Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ 2008;86:480–7.ModellBDarlisonM.Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ2008;86:480–7.10.2471/BLT.06.036673264747318568278Search in Google Scholar
Serjeant GR. Sickle-cell disease. Lancet 1997;350:725–30.SerjeantGR.Sickle-cell disease. Lancet1997;350:725–30.10.1016/S0140-6736(97)07330-39291916Search in Google Scholar
Piel FB, Patil AP, Howes RE, et al. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet 2013;381: 142–51.PielFBPatilAPHowesREGlobal epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet2013;381: 142–51.10.1016/S0140-6736(12)61229-X354724923103089Search in Google Scholar
Fleming AF, Storey J, Molineaux L, et al. Abnormal haemoglobins in the Sudan savanna of Nigeria. I. Prevalence of haemoglobins and relationships between sickle cell trait, malaria and survival. Ann Trop Med Parasitol 1979;73: 161–72.FlemingAFStoreyJMolineauxLAbnormal haemoglobins in the Sudan savanna of Nigeria. I. Prevalence of haemoglobins and relationships between sickle cell trait, malaria and survival. Ann Trop Med Parasitol1979;73: 161–72.10.1080/00034983.1979.11687243315211Search in Google Scholar
Uzoegwu PN, Onwurah AE. Prevalence of haemoglobinopathy and malaria diseases in the population of Old Aguata Division, Anambra State, Nigeria. Biokemstri 2003;15:57–66.UzoegwuPNOnwurahAE.Prevalence of haemoglobinopathy and malaria diseases in the population of Old Aguata Division, Anambra State, Nigeria. Biokemstri2003;15:57–66.Search in Google Scholar
Nwogoh B, Adewoyin AS, Iheanacho OE, Bazuaye GN. Prevalence of haemoglobin variants in Benin City, Nigeria. Ann Biomed Sci 2012;11:60–4.NwogohBAdewoyinASIheanachoOEBazuayeGN.Prevalence of haemoglobin variants in Benin City, Nigeria. Ann Biomed Sci2012;11:60–4.Search in Google Scholar
Makani J, Ofori-Acquah SF, Nnodu O, Wonkam A, Ohene-Frempong K. Sickle cell disease: new opportunities and challenges in Africa. Scientific World Journal 2013:2013: 193252. Available from http://dx.doi.org/10.1155/2013/193252. Accessed 26 August 2021MakaniJOfori-AcquahSFNnoduOWonkamAOhene-FrempongK.Sickle cell disease: new opportunities and challenges in Africa. Scientific World Journal2013:2013: 193252. Available from http://dx.doi.org/10.1155/2013/193252. Accessed 26 August 202110.1155/2013/193252398889225143960Search in Google Scholar
Lesi FE. Problems related to the management of sickle cell disease in Nigeria. Am J Pediatr Hematol Oncol 1982;4:55–9.LesiFE.Problems related to the management of sickle cell disease in Nigeria. Am J Pediatr Hematol Oncol1982;4:55–9.Search in Google Scholar
Genetic disorders of haemoglobin. In: Hoffbrand AV, Moss PAH, Pettit JE, Eds. Essential haematology. 5th ed. London: Blackwell Publishing, 2006:72–93.Genetic disorders of haemoglobin. In: HoffbrandAVMossPAHPettitJE Eds. Essential haematology. 5th ed. London: Blackwell Publishing, 2006:72–93.Search in Google Scholar
Hsieh MM, Tisdale JF, Rodgers GP. Haemolytic anaemia: thalassemias and sickle cell disorders. In: Rodgers GP, Young NS, Eds. The Bethesda handbook of clinical haematology. 3rd ed. Philadelphia, PA: Lippincott Williams and Wilkins, 2013:37–56.HsiehMMTisdaleJFRodgersGP.Haemolytic anaemia: thalassemias and sickle cell disorders. In: RodgersGPYoungNS Eds. The Bethesda handbook of clinical haematology. 3rd ed. Philadelphia, PA: Lippincott Williams and Wilkins, 2013:37–56.Search in Google Scholar
Galacteros F, de Montalembert M. Sickle cell disease: a short guide to management. In: Beaumont C, Beris P, Beuzard Y, Brugnara C, Eds. ESH handbook on disorders of erythropoiesis, erythrocytes and iron metabolism. Available from https://www.esh.org/files/doc/IRON2009_CAP.13.1%28310-327%29.pdf. Accessed 26 August 2021.GalacterosFde MontalembertM.Sickle cell disease: a short guide to management. In: BeaumontCBerisPBeuzardYBrugnaraC Eds. ESH handbook on disorders of erythropoiesis, erythrocytes and iron metabolism. Available from https://www.esh.org/files/doc/IRON2009_CAP.13.1%28310-327%29.pdf. Accessed 26 August 2021.Search in Google Scholar
Wayne AS, Kevy SV, Nathan DG. Transfusion management of sickle cell disease. Blood 1993;81:1109–23.WayneASKevySVNathanDG.Transfusion management of sickle cell disease. Blood1993;81:1109–23.10.1182/blood.V81.5.1109.bloodjournal8151109Search in Google Scholar
Rogers ZR. Review: clinical transfusion management in sickle cell disease. Immunohematology 2006;22:126–31.RogersZR.Review: clinical transfusion management in sickle cell disease. Immunohematology2006;22:126–31.10.21307/immunohematology-2019-369Search in Google Scholar
Lagunju AI, Brown BJ, Sodeinde OO. Chronic blood transfusion for primary and secondary stroke prevention in Nigerian children with sickle cell disease: a five-year appraisal. Pediatr Blood Cancer 2013;60:1940–5.LagunjuAIBrownBJSodeindeOO.Chronic blood transfusion for primary and secondary stroke prevention in Nigerian children with sickle cell disease: a five-year appraisal. Pediatr Blood Cancer2013;60:1940–5.10.1002/pbc.2469823956197Search in Google Scholar
Diaku-Akinwumi IN, Abubakar SB, Adegoke SA, et al. Blood transfusion services for patients with sickle cell disease in Nigeria. Int Health 2016;pii:ihw014.Diaku-AkinwumiINAbubakarSBAdegokeSABlood transfusion services for patients with sickle cell disease in Nigeria. Int Health2016;pii:ihw014.Search in Google Scholar
Otaigbe B. Prevalence of blood transfusion in sickle cell anaemia patients in South-South Nigeria: a two-year experience. Int J Med Med Sci Res 2013;1:13–8.OtaigbeB.Prevalence of blood transfusion in sickle cell anaemia patients in South-South Nigeria: a two-year experience. Int J Med Med Sci Res2013;1:13–8.Search in Google Scholar
Animasahun BA, Bode-Thomas F, Temiye EO, Njokanma OF. Clinical profile of Nigerian children with sickle cell anaemia. Curr Pediatr Res 2013;17:95–9.AnimasahunBABode-ThomasFTemiyeEONjokanmaOF.Clinical profile of Nigerian children with sickle cell anaemia. Curr Pediatr Res2013;17:95–9.Search in Google Scholar
Hauck-Dlimi B, Achenbach S, Strobel J, Eckstein R, Zimmermann R. Prevention and management of transfusion-induced alloimmunization: current perspectives. Int J Clin Transfus Med 2014;2:59–63.Hauck-DlimiBAchenbachSStrobelJEcksteinRZimmermannR.Prevention and management of transfusion-induced alloimmunization: current perspectives. Int J Clin Transfus Med2014;2:59–63.10.2147/IJCTM.S40028Search in Google Scholar
Contreras M, Taylor Clare PF, Barbara JA. Clinical blood transfusion. In: Hoffbrand AV, Catovsky D, Tuddenham EGD, Green AR, Eds. Postgraduate haematology. 6th ed. West Sussex: Wiley-Blackwell, 2011:268–99.ContrerasMTaylor ClarePFBarbaraJA.Clinical blood transfusion. In: HoffbrandAVCatovskyDTuddenhamEGDGreenAR Eds. Postgraduate haematology. 6th ed. West Sussex: Wiley-Blackwell, 2011:268–99.Search in Google Scholar
Cox JV, Steane E, Cunningham G, Frenkel E. Risk of alloimmunization and delayed haemolytic transfusion reactions in patients with sickle cell disease. Arch Intern Med 1988;148:2485–9.CoxJVSteaneECunninghamGFrenkelE.Risk of alloimmunization and delayed haemolytic transfusion reactions in patients with sickle cell disease. Arch Intern Med1988;148:2485–9.10.1001/archinte.1988.00380110115024Search in Google Scholar
Kuliya-Gwarzo A, Akanmu AS, Dutse AI. Prevalence of red cell alloantibodies in multitransfused patients with sickle cell anaemia in Northern Nigeria. Africa Sang 2005;8:1–4.Kuliya-GwarzoAAkanmuASDutseAI.Prevalence of red cell alloantibodies in multitransfused patients with sickle cell anaemia in Northern Nigeria. Africa Sang2005;8:1–4.Search in Google Scholar
Ugwu NI, Awodu OA, Bazuaye GN, Okoye AE. Red cell alloimmunisation in multi-transfused patients with sickle cell anaemia in Benin City, Nigeria. Niger J Clin Pract 2015;18:522–6.UgwuNIAwoduOABazuayeGNOkoyeAE.Red cell alloimmunisation in multi-transfused patients with sickle cell anaemia in Benin City, Nigeria. Niger J Clin Pract2015;18:522–6.10.4103/1119-3077.15420425966726Search in Google Scholar
Kangiwa U, Ibegbulam O, Ocheni S, Madu A, Mohammed N. Pattern and prevalence of alloimmunisation in multiply transfused patients with sickle cell disease in Nigeria. Biomarker Res 2015;3:26.KangiwaUIbegbulamOOcheniSMaduAMohammedN.Pattern and prevalence of alloimmunisation in multiply transfused patients with sickle cell disease in Nigeria. Biomarker Res2015;3:26.10.1186/s40364-015-0050-3460377026464798Search in Google Scholar
Natukunda B, Schonewille H, Ndugwa C, Brand A. Red blood cell alloimmunization in sickle cell disease patients in Uganda. Transfusion 2010;50:20–5.NatukundaBSchonewilleHNdugwaCBrandA.Red blood cell alloimmunization in sickle cell disease patients in Uganda. Transfusion2010;50:20–5.10.1111/j.1537-2995.2009.02435.x19821949Search in Google Scholar
Zanetter AMD, Goncalves MS, Schettini LV, et al. Alloimmunisation and clinical profile of sickle cell disease patients from Salvador-Brazil. Ethn Dis 2010;20:136–41.ZanetterAMDGoncalvesMSSchettiniLVAlloimmunisation and clinical profile of sickle cell disease patients from Salvador-Brazil. Ethn Dis2010;20:136–41.Search in Google Scholar
Olujohungbe A, Hambleton I, Stephens L, Serjeant B, Sergeant G. Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United Kingdom. Br J Haematol 2001;113:661–5.OlujohungbeAHambletonIStephensLSerjeantBSergeantG.Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United Kingdom. Br J Haematol2001;113:661–5.10.1046/j.1365-2141.2001.02819.x11380455Search in Google Scholar
Bashawri LAM. Red cell alloimmunisation in sickle cell anaemia patients. East Mediterr Health J 2007;13:1181–9.BashawriLAM.Red cell alloimmunisation in sickle cell anaemia patients. East Mediterr Health J2007;13:1181–9.10.26719/2007.13.5.118118290412Search in Google Scholar
Sins JMR, Biermond BJ, van den Bersselaar SM, et al. Early occurrence of red blood cell alloimmunization in patients with sickle cell disease. Am J Hematol 2016;91:763–9.SinsJMRBiermondBJvan den BersselaarSMEarly occurrence of red blood cell alloimmunization in patients with sickle cell disease. Am J Hematol2016;91:763–9.10.1002/ajh.2439727102719Search in Google Scholar
Verduin EP, Brand A, Middleburg RA, Schonewille H. Female sex of older patients is an independent risk factor for red blood cell alloimmunisation after transfusion. Transfusion 2015;55:1478–85.VerduinEPBrandAMiddleburgRASchonewilleH.Female sex of older patients is an independent risk factor for red blood cell alloimmunisation after transfusion. Transfusion2015;55:1478–85.10.1111/trf.1311125846865Search in Google Scholar
Allali S, Peyrard T, Amiranoff D, et al. Prevalence and risk factors for red blood cell alloimmunisation in 175 children with sickle cell disease in a French University Hospital Reference Centre. Br J Haematol 2017;177:641–7.AllaliSPeyrardTAmiranoffDPrevalence and risk factors for red blood cell alloimmunisation in 175 children with sickle cell disease in a French University Hospital Reference Centre. Br J Haematol2017;177:641–7.10.1111/bjh.1460928402005Search in Google Scholar
Desai PC, Deal AM, Pfaff ER, et al. Alloimmunisation is associated with older age of transfused red blood cells in sickle cell disease. Am J Hematol 2015;90:691–5.DesaiPCDealAMPfaffERAlloimmunisation is associated with older age of transfused red blood cells in sickle cell disease. Am J Hematol2015;90:691–5.10.1002/ajh.24051502228325963831Search in Google Scholar
Garg N, Sharma T, Singh B. Prevalence of irregular red blood cell antibodies among healthy blood donors in Delhi population. Transfus Apher Sci 2014;50:415–7.GargNSharmaTSinghB.Prevalence of irregular red blood cell antibodies among healthy blood donors in Delhi population. Transfus Apher Sci2014;50:415–7.10.1016/j.transci.2014.03.00424797241Search in Google Scholar
Roback JD, Combs MR, Grossman BJ, et al., Eds. Technical manual. 16th ed. Bethesda, MD: American Association of Blood Banks, 2008.RobackJDCombsMRGrossmanBJ, Eds. Technical manual. 16th ed. Bethesda, MD: American Association of Blood Banks, 2008.Search in Google Scholar
Regan F. Blood cell antigens and antibodies: erythrocytes, platelets and granulocytes. In: Bain BJ, Bates I, Laffan MA, Lewis SM, Eds. Dacie and Lewis practical haematology. 11th ed. London: Elsevier Churchill Livingstone Publishers, 2012:483–517.ReganF.Blood cell antigens and antibodies: erythrocytes, platelets and granulocytes. In: BainBJBatesILaffanMALewisSM Eds. Dacie and Lewis practical haematology. 11th ed. London: Elsevier Churchill Livingstone Publishers, 2012:483–517.10.1016/B978-0-7020-3408-4.00021-7Search in Google Scholar
Schonewille H, Haak HL, van Zijl AM. RBC antibody persistence. Transfusion 2000;40:1127–31.SchonewilleHHaakHLvan ZijlAM.RBC antibody persistence. Transfusion2000;40:1127–31.10.1046/j.1537-2995.2000.40091127.x10988317Search in Google Scholar
Josephson CD, Su LL, Hillyer KL, Hillyer CD. Transfusion in the patient with sickle cell disease: a critical review of literature and transfusion guidelines. Trans Med Rev 2007;21:118–33.JosephsonCDSuLLHillyerKLHillyerCD.Transfusion in the patient with sickle cell disease: a critical review of literature and transfusion guidelines. Trans Med Rev2007;21:118–33.10.1016/j.tmrv.2006.11.00317397762Search in Google Scholar
Natukunda B, Schonewille H, Ndugwa C, Brand A. Red blood cell alloimmunisation in sickle cell disease patients in Uganda. Transfusion 2010;50:20–5.NatukundaBSchonewilleHNdugwaCBrandA.Red blood cell alloimmunisation in sickle cell disease patients in Uganda. Transfusion2010;50:20–5.10.1111/j.1537-2995.2009.02435.x19821949Search in Google Scholar
